LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
0.31623
 54.49 770.25 3790 7555 0.5016 0.6221
MN20160304_L02
H20
MCF 10A-H2B-mCherry Dasatinib
0.31623
 54.49 770.25 3341 7555 0.4422 0.5612
MN20160304_L02
K06
MCF 10A-H2B-mCherry Dasatinib
0.31623
 56.71 770.25 3949 8001 0.4935 0.6226
MN20160304_L02
H19
MCF 10A-H2B-mCherry Dasatinib
0.31623
 56.71 770.25 3990 8001 0.4987 0.6276
MN20160304_L02
H20
MCF 10A-H2B-mCherry Dasatinib
0.31623
 56.71 770.25 3534 8001 0.4417 0.5701
MN20160304_L02
K06
MCF 10A-H2B-mCherry Dasatinib
0.31623
 58.94 770.25 4198 8444 0.4971 0.6337
MN20160304_L02
H19
MCF 10A-H2B-mCherry Dasatinib
0.31623
 58.94 770.25 4300 8444 0.5092 0.6451
MN20160304_L02
H20
MCF 10A-H2B-mCherry Dasatinib
0.31623
 58.94 770.25 3733 8444 0.4421 0.5791
MN20160304_L02
K06
MCF 10A-H2B-mCherry Dasatinib
0.31623
 61.16 770.25 4388 8892 0.4935 0.6373
MN20160304_L02
H19
MCF 10A-H2B-mCherry Dasatinib
0.31623
 61.16 770.25 4460 8892 0.5016 0.6448
MN20160304_L02
H20
MCF 10A-H2B-mCherry Dasatinib
0.31623
 61.16 770.25 3870 8892 0.4352 0.5800
MN20160304_L02
K06
MCF 10A-H2B-mCherry Dasatinib
0.31623
 63.39 770.25 4655 9326 0.4991 0.6487
MN20160304_L02
H19
MCF 10A-H2B-mCherry Dasatinib
0.31623
 63.39 770.25 4849 9326 0.5199 0.6676
MN20160304_L02
H20
MCF 10A-H2B-mCherry Dasatinib
0.31623
 63.39 770.25 4069 9326 0.4363 0.5882
MN20160304_L02
K06
MCF 10A-H2B-mCherry Dasatinib
0.31623
 65.61 770.25 4875 9736 0.5007 0.6556
MN20160304_L02
H19
MCF 10A-H2B-mCherry Dasatinib
0.31623
 65.61 770.25 5007 9736 0.5143 0.6677
MN20160304_L02
H20
MCF 10A-H2B-mCherry Dasatinib
0.31623
 65.61 770.25 4294 9736 0.4410 0.5992
MN20160304_L02
K06
MCF 10A-H2B-mCherry Dasatinib
0.31623
 67.83 770.25 5108 10078 0.5068 0.6652
MN20160304_L02
H19
MCF 10A-H2B-mCherry Dasatinib
0.31623
 67.83 770.25 5171 10078 0.5131 0.6707
MN20160304_L02
H20
MCF 10A-H2B-mCherry Dasatinib
0.31623
 67.83 770.25 4485 10078 0.4450 0.6079
MN20160304_L02
K06
MCF 10A-H2B-mCherry Dasatinib
0.31623
 70.05 770.25 5400 10413 0.5186 0.6793
MN20160304_L02
H19
MCF 10A-H2B-mCherry Dasatinib
0.31623
 70.05 770.25 5387 10413 0.5173 0.6782
MN20160304_L02
H20
MCF 10A-H2B-mCherry Dasatinib
0.31623
 70.05 770.25 4670 10413 0.4485 0.6156
MN20160304_L02
K06
MCF 10A-H2B-mCherry Dasatinib
0.31623
 72.27 770.25 5674 10730 0.5288 0.6913
MN20160304_L02
H19
MCF 10A-H2B-mCherry Dasatinib
0.31623
 72.27 770.25 5655 10730 0.5270 0.6898
MN20160304_L02
H20